Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (11)
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
  • Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
Find Similar Products
  • Overview
  • Product Description
Overview

Basic Info.

Model NO.
Thymosin Alpha 1
Certification
GMP, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Solid
Purity
>99%
Color
White
OEM
Yes
Reship
Reship If Stuck in Custom
MOQ
1box
Transport Package
Box
Specification
10mg/vial; 10vial/box
Trademark
QSC
Origin
China

Product Description

Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
Product Description

Physical Characters and specifications

name:Thymosin α1 Acetate
Cas No: 62304-98-7
Formula: C129H215N33O55
Molecular:3108.3
Sequence:Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Purity:98%
Appearance: white fine powder
Source: synthetic

Product introduction
Thymosin α1 is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene.

It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Unlike β thymosins, to which it is genetically and chemically unrelated, thymosin α1 is produced as a 28-amino acid fragment, from a longer, 113-amino acid precursor, prothymosin α.
 

Function
Thymosin α1 is believed to be a major component of Thymosin Fraction 5 responsible for the activity of that preparation in restoring immune function in animals lacking thymus glands. It has been found to enhance cell-mediated immunity in humans as well as experimental animals.
 

Therapeutic application
As of 2009 Thymosin α1 is approved in 35 under-developed or developing countries for the treatment ofHepatitis B and C, and it is also used to boost the immune response in the treatment of other diseases

Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1
Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1

Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1

Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1Pharmaceutical Peptide CAS: 62304-98-7 Thymosin Alpha 1

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier